Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2021-04, Vol.84 (4), p.1098-1100 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1100 |
|---|---|
| container_issue | 4 |
| container_start_page | 1098 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 84 |
| creator | Mahmoudi, Hamidreza Farid, Ali Salehi Nili, Ali Dayani, Dorsa Tavakolpour, Soheil Soori, Tahereh Teimourpour, Amir Isazade, Ahdie Abedini, Robabeh Balighi, Kamran Daneshpazhooh, Maryam |
| description | |
| doi_str_mv | 10.1016/j.jaad.2020.12.043 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7836213</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962220332370</els_id><sourcerecordid>2473405019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-564e3a43924875b722dd0150b5c4e4c681aa7fc445b84fb7a36e69ae0bbcabf73</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS0EotvCF-CAfOSSxX_jBCGkailQqVIvLVdr4kxYr5J4sZ1F_fZ4taWCCydL4zdvZt6PkDecrTnj9fvdegfQrwUTpSDWTMlnZMVZa6raNOY5WTHesqqthTgj5yntGGOtkuYlOZNS6la3ckXSZgsRXMboU_YuUZh7GpbswoSJhoFubr9ff654S_1M95A9zjnRXz5vKSw5-GlaZqTdMo5hSbT3CSFh-kAvacQcQ9qjy_6A1IVtiJmmvPQPr8iLAcaErx_fC3L_5epu8626uf16vbm8qZzSOle6VihByVaoxujOCNH3jGvWaadQubrhAGZwSumuUUNnQNZYt4Cs6xx0g5EX5NPJd790E_aurB5htPvoJ4gPNoC3__7Mfmt_hIM1jawFl8Xg3aNBDD8XTNlOPjkcR5ixnGuFMlIxXWIuUnGSunJ0ijg8jeHMHmnZnT3SskdalgtbaJWmt38v-NTyB08RfDwJsMR08BhtcoWAw97HEqztg_-f_2-bP6j8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473405019</pqid></control><display><type>article</type><title>Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mahmoudi, Hamidreza ; Farid, Ali Salehi ; Nili, Ali ; Dayani, Dorsa ; Tavakolpour, Soheil ; Soori, Tahereh ; Teimourpour, Amir ; Isazade, Ahdie ; Abedini, Robabeh ; Balighi, Kamran ; Daneshpazhooh, Maryam</creator><creatorcontrib>Mahmoudi, Hamidreza ; Farid, Ali Salehi ; Nili, Ali ; Dayani, Dorsa ; Tavakolpour, Soheil ; Soori, Tahereh ; Teimourpour, Amir ; Isazade, Ahdie ; Abedini, Robabeh ; Balighi, Kamran ; Daneshpazhooh, Maryam ; Autoimmune Bullous Diseases Research Group</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2020.12.043</identifier><identifier>PMID: 33359593</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Anti-Inflammatory Agents - therapeutic use ; Autoimmune Diseases - drug therapy ; COVID-19 - epidemiology ; Female ; Hospitalization - statistics & numerical data ; Humans ; Immunologic Factors - therapeutic use ; Iran - epidemiology ; Male ; Middle Aged ; Prednisolone - therapeutic use ; Prognosis ; Research Letter ; Retrospective Studies ; Risk Factors ; Rituximab - therapeutic use ; SARS-CoV-2 ; Skin Diseases, Vesiculobullous - drug therapy ; Skin Diseases, Vesiculobullous - immunology</subject><ispartof>Journal of the American Academy of Dermatology, 2021-04, Vol.84 (4), p.1098-1100</ispartof><rights>2020 American Academy of Dermatology, Inc.</rights><rights>2020 by the American Academy of Dermatology, Inc. 2020 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-564e3a43924875b722dd0150b5c4e4c681aa7fc445b84fb7a36e69ae0bbcabf73</citedby><cites>FETCH-LOGICAL-c455t-564e3a43924875b722dd0150b5c4e4c681aa7fc445b84fb7a36e69ae0bbcabf73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2020.12.043$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33359593$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahmoudi, Hamidreza</creatorcontrib><creatorcontrib>Farid, Ali Salehi</creatorcontrib><creatorcontrib>Nili, Ali</creatorcontrib><creatorcontrib>Dayani, Dorsa</creatorcontrib><creatorcontrib>Tavakolpour, Soheil</creatorcontrib><creatorcontrib>Soori, Tahereh</creatorcontrib><creatorcontrib>Teimourpour, Amir</creatorcontrib><creatorcontrib>Isazade, Ahdie</creatorcontrib><creatorcontrib>Abedini, Robabeh</creatorcontrib><creatorcontrib>Balighi, Kamran</creatorcontrib><creatorcontrib>Daneshpazhooh, Maryam</creatorcontrib><creatorcontrib>Autoimmune Bullous Diseases Research Group</creatorcontrib><title>Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>Adult</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Autoimmune Diseases - drug therapy</subject><subject>COVID-19 - epidemiology</subject><subject>Female</subject><subject>Hospitalization - statistics & numerical data</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Iran - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prednisolone - therapeutic use</subject><subject>Prognosis</subject><subject>Research Letter</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Rituximab - therapeutic use</subject><subject>SARS-CoV-2</subject><subject>Skin Diseases, Vesiculobullous - drug therapy</subject><subject>Skin Diseases, Vesiculobullous - immunology</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS0EotvCF-CAfOSSxX_jBCGkailQqVIvLVdr4kxYr5J4sZ1F_fZ4taWCCydL4zdvZt6PkDecrTnj9fvdegfQrwUTpSDWTMlnZMVZa6raNOY5WTHesqqthTgj5yntGGOtkuYlOZNS6la3ckXSZgsRXMboU_YuUZh7GpbswoSJhoFubr9ff654S_1M95A9zjnRXz5vKSw5-GlaZqTdMo5hSbT3CSFh-kAvacQcQ9qjy_6A1IVtiJmmvPQPr8iLAcaErx_fC3L_5epu8626uf16vbm8qZzSOle6VihByVaoxujOCNH3jGvWaadQubrhAGZwSumuUUNnQNZYt4Cs6xx0g5EX5NPJd790E_aurB5htPvoJ4gPNoC3__7Mfmt_hIM1jawFl8Xg3aNBDD8XTNlOPjkcR5ixnGuFMlIxXWIuUnGSunJ0ijg8jeHMHmnZnT3SskdalgtbaJWmt38v-NTyB08RfDwJsMR08BhtcoWAw97HEqztg_-f_2-bP6j8</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Mahmoudi, Hamidreza</creator><creator>Farid, Ali Salehi</creator><creator>Nili, Ali</creator><creator>Dayani, Dorsa</creator><creator>Tavakolpour, Soheil</creator><creator>Soori, Tahereh</creator><creator>Teimourpour, Amir</creator><creator>Isazade, Ahdie</creator><creator>Abedini, Robabeh</creator><creator>Balighi, Kamran</creator><creator>Daneshpazhooh, Maryam</creator><general>Elsevier Inc</general><general>by the American Academy of Dermatology, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210401</creationdate><title>Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study</title><author>Mahmoudi, Hamidreza ; Farid, Ali Salehi ; Nili, Ali ; Dayani, Dorsa ; Tavakolpour, Soheil ; Soori, Tahereh ; Teimourpour, Amir ; Isazade, Ahdie ; Abedini, Robabeh ; Balighi, Kamran ; Daneshpazhooh, Maryam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-564e3a43924875b722dd0150b5c4e4c681aa7fc445b84fb7a36e69ae0bbcabf73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Autoimmune Diseases - drug therapy</topic><topic>COVID-19 - epidemiology</topic><topic>Female</topic><topic>Hospitalization - statistics & numerical data</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Iran - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prednisolone - therapeutic use</topic><topic>Prognosis</topic><topic>Research Letter</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Rituximab - therapeutic use</topic><topic>SARS-CoV-2</topic><topic>Skin Diseases, Vesiculobullous - drug therapy</topic><topic>Skin Diseases, Vesiculobullous - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahmoudi, Hamidreza</creatorcontrib><creatorcontrib>Farid, Ali Salehi</creatorcontrib><creatorcontrib>Nili, Ali</creatorcontrib><creatorcontrib>Dayani, Dorsa</creatorcontrib><creatorcontrib>Tavakolpour, Soheil</creatorcontrib><creatorcontrib>Soori, Tahereh</creatorcontrib><creatorcontrib>Teimourpour, Amir</creatorcontrib><creatorcontrib>Isazade, Ahdie</creatorcontrib><creatorcontrib>Abedini, Robabeh</creatorcontrib><creatorcontrib>Balighi, Kamran</creatorcontrib><creatorcontrib>Daneshpazhooh, Maryam</creatorcontrib><creatorcontrib>Autoimmune Bullous Diseases Research Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahmoudi, Hamidreza</au><au>Farid, Ali Salehi</au><au>Nili, Ali</au><au>Dayani, Dorsa</au><au>Tavakolpour, Soheil</au><au>Soori, Tahereh</au><au>Teimourpour, Amir</au><au>Isazade, Ahdie</au><au>Abedini, Robabeh</au><au>Balighi, Kamran</au><au>Daneshpazhooh, Maryam</au><aucorp>Autoimmune Bullous Diseases Research Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>84</volume><issue>4</issue><spage>1098</spage><epage>1100</epage><pages>1098-1100</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33359593</pmid><doi>10.1016/j.jaad.2020.12.043</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0190-9622 |
| ispartof | Journal of the American Academy of Dermatology, 2021-04, Vol.84 (4), p.1098-1100 |
| issn | 0190-9622 1097-6787 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7836213 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Anti-Inflammatory Agents - therapeutic use Autoimmune Diseases - drug therapy COVID-19 - epidemiology Female Hospitalization - statistics & numerical data Humans Immunologic Factors - therapeutic use Iran - epidemiology Male Middle Aged Prednisolone - therapeutic use Prognosis Research Letter Retrospective Studies Risk Factors Rituximab - therapeutic use SARS-CoV-2 Skin Diseases, Vesiculobullous - drug therapy Skin Diseases, Vesiculobullous - immunology |
| title | Characteristics and outcomes of COVID-19 in patients with autoimmune bullous diseases: A retrospective cohort study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T14%3A00%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20outcomes%20of%20COVID-19%20in%20patients%20with%20autoimmune%20bullous%20diseases:%20A%20retrospective%20cohort%20study&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Mahmoudi,%20Hamidreza&rft.aucorp=Autoimmune%20Bullous%20Diseases%20Research%20Group&rft.date=2021-04-01&rft.volume=84&rft.issue=4&rft.spage=1098&rft.epage=1100&rft.pages=1098-1100&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2020.12.043&rft_dat=%3Cproquest_pubme%3E2473405019%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473405019&rft_id=info:pmid/33359593&rft_els_id=S0190962220332370&rfr_iscdi=true |